Liu, Xiaoni
Bristol-Myers Squibb (United States)
2 papers on CoChatORCID 0000-0003-1101-4013
Most cited papers
- Verified
Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes
DeFronzo, R. A., Hompesch, M., Kasichayanula, S., Liu, X., Hong, Y., Pfister, M., Morrow, L. A., Leslie, B. R., Boulton, D. W., Ching, A., et al. (2013) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 293
- Verified
Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2
Kasichayanula, S., Liu, X., LaCreta, F., Griffen, S. C., & Boulton, D. W. (2014) · Clinical Pharmacokinetics
Diabetes Treatment and ManagementPharmacogenetics and Drug Metabolism
Cited by 276
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free